Latest New Zealand News

Big River Industries is set to acquire John’s Building Supplies for up to $17 million, backed by a fully underwritten $10 million entitlement offer to fund the deal. This move strengthens Big River’s presence in Western Australia’s growing building materials market.

Eagle Mountain Mining has initiated a non-renounceable entitlement offer to raise nearly $2 million, aiming to accelerate exploration at its Silver Mountain Project in Arizona. The offer includes attaching options and targets eligible shareholders across select countries.

Whitefield Industrials Limited has announced a fully franked ordinary dividend of AUD 0.105 per share for the half-year ending September 2025, alongside shareholder reinvestment options.

Paragon Care Limited is set to acquire Indonesian medical aesthetics leader Haju Medical for A$70 million, aiming to boost its footprint across Asia Pacific and accelerate growth in the aesthetics sector.

Terra Critical Minerals has launched a non-renounceable entitlement offer of quoted options to eligible shareholders, aiming to raise $586,302 in working capital with potential for $5.3 million if all options are exercised. The offer provides shareholders speculative exposure to the company’s critical and precious metals projects across Australia and North America.

Activeport Group Ltd has revised the timetable for its pro-rata bonus issue of unquoted options, outlining key dates and eligible shareholders across multiple countries.

Merino & Co. Limited has unveiled a robust growth plan at its 2025 AGM, highlighting strengthened finances, operational expansion, and a clear focus on sustainability and premium brand positioning in the global apparel market.

Alma Metals has launched a $2.5 million Share Purchase Plan offering Australian and New Zealand shareholders discounted shares to fund its Briggs Copper Project drilling and working capital needs.

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.

VHM Limited has launched a non-underwritten Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to invest up to $30,000 at $0.35 per share, a significant discount to recent trading prices. The capital raised will support key development stages of the Goschen Project ahead of a final investment decision in early 2026.

Vysarn Limited has reported record FY25 profits and is aiming for a 33% NPBT increase in FY26, driven by acquisitions and progress on the Kariyarra Water Scheme. The company is expanding its national footprint amid growing water demand in mining and infrastructure sectors.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.